c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. [electronic resource]
Producer: 19920318Description: 1107-13 p. digitalISSN:- 0008-5472
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.